Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
DongKook Pharmaceutical Co., Ltd. (086450)
Market Closed
11 Aug, 06:30
KRX SM
All
(2)
KR
(2)
KRX SM
Primary
KOSDAQ
₩
21,550.
00
+1,450
+7.2139%
₩
989.94B
Market Cap
-
P/E Ratio
720%
Div Yield
154,579
Volume
-
Eps
₩
20,100
Previous Close
Watching
Watch
Add Transaction
Day Range
20,050
21,750
Year Range
16,260
31,250
Want to track
086450
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
DongKook Pharmaceutical Co., Ltd. (086450) Statistics
Valuation metrics
Market Cap
989.94B
Enterprise value
879.92B
Trailing P/E (ttm)
11.59
Forward P/E
10.07
PEG ratio
0.43
Price/Sales (ttm)
0.91
Price/Book (mrq)
1.28
Enterprise Value/Revenue
0.92
Enterprise Value/EBITDA
6.73
Overview
Shares outstanding
8.79M
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
223.08K
Average volume (90 days)
365.93K
Price summary
52-Week low
16,260
52-Week high
31,250
Beta
-
50-Day moving average
18,570.86
200-Day moving average
20,432.96
Dividends and splits
Forward annual dividend rate
720
Forward annual dividend yield
0.0323%
Trailing annual dividend rate
200
Trailing annual dividend yield
0.0104%
5-Year annual dividend yield
-
Payout ratio
0.12
Dividend Date
1 Apr 2026
Ex-Dividend Date
29 Dec 2025
Last split factor
5:1
Last split Date
10 Sep 2020
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.08%
Operating margin
0.1%
Operational effectiveness
Return on assets
0.07%
Return on equity
0.11%
Income Statement
Revenue (ttm)
926.88B
Revenue per share (ttm)
21,151.47
Quarterly revenue growth (yoy)
0.03%
Gross profit (ttm)
501.6B
EBITDA
130.13B
Net income to common (ttm)
66.02B
Diluted EPS (ttm)
1,651.87
Quarterly earnings growth (yoy)
0.12%
Balance Sheet
Total cash (mrq)
10.6M
Total cash per share (mrq)
2,623.77
Total debt (mrq)
67.98B
Total Debt/Equity (mrq)
0.1
Current ratio (mrq)
2.06%
Book value per share (mrq)
17,326.78
Cash Flow
Cash flow statement
2.17B
Levered free cash flow (LFCF)
66.02B